Pilot Effort Helps States Negotiate Rx Prices Within Medicaid Drug Rebate Program

States can use alternative payment models to bring prescription drug companies to the negotiating table and lower prices of drugs in the Medicaid drug rebate program without changing laws, researchers from Oregon Health & Science University told congressional advisers on Friday (March 3). The research comes as Republican governors push lawmakers to include in their ACA replacement package a provision that would end the requirement that states cover every FDA-approved drug. The university’s Center for Evidence-based Policy launched a three-year...